EMAIL: [email protected]
PHONE: 720.643.4450

Kristen Nichols

Kristen is a Denver-based reporter for Marijuana Business Daily specializing in the hemp and CBD industries. Previously, she worked at the Associated Press for nearly 20 years. She started covering the marijuana legalization movement in 2009 – when medical stores started popping up around Denver – and wrote about the state’s first legal hemp harvest. Kristen also covered agriculture and politics in Maryland and her home state of Georgia

GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug

A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company’s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians […]

Read More

Linton back in cannabis business as chair, investor and adviser

Ousted Canopy Growth co-CEO Bruce Linton is getting back into the marijuana business in a big way, resurfacing as a senior executive, investor and adviser in three separate companies in the U.S. and Canada. Linton is joining Michigan-based Gage Cannabis Co. as executive chair, parent company Wolverine Partners said Tuesday. Gage said in a news […]

Read More

Anti-cannabis governor targets hemp, saying plant too close for police

A Republican governor who strongly opposes cannabis legalization says that allowing hemp cultivation is just as problematic. South Dakota Gov. Kristi Noem took her argument national in The Wall Street Journal, arguing in an op-ed column that law enforcement doesn’t have the testing capacity to discern between marijuana and legal hemp, which has no more […]

Read More

‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker

Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London’s GW Pharma (Nasdaq: GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales and new patient enrollments since the […]

Read More

Texas mulls a broadened limited medical marijuana program

Texas is looking at dramatically expanding its limited medical cannabis program to allow patients with a range of new medical conditions, from post-traumatic stress disorder to cancer, to qualify for marijuana-derived oils high in CBD. A bill was approved 7-1 by the House Committee on Public Health and is awaiting a vote in the Texas […]

Read More

Georgia lifts ban on commercial medical marijuana production

Georgia Gov. Brian Kemp has opened the state to commercial medical cannabis cultivation, signing a bill to create new business opportunities in the Peach State’s limited MMJ program. The measure outlines the first opportunities for private businesses to grow and sell cannabis. Georgia launched its limited MMJ program in 2015, though the cultivation, manufacture or sale of THC […]

Read More

Georgia poised to lift cultivation ban for limited medical cannabis program

Georgia lawmakers want to open the state to commercial medical marijuana cultivation, passing a bill that would offer fresh business opportunities in the Peach State’s limited MMJ program. The measure awaits the signature of Gov. Brian Kemp, who has indicated he supports offering in-state medical marijuana cultivation, according to The Atlanta Journal-Constitution. Georgia launched a limited MMJ program […]

Read More

Marijuana or hemp? Manufacturers snagged by Farm Bill confusion

Cannabis entrepreneurs say they’re facing jail time and hefty legal fees because of the plant’s complicated biology, with the vaunted 2018 Farm Bill only muddling the picture for interstate commerce. A pair of cases in Idaho and Oklahoma raised questions about how state and local law enforcement are supposed to tell the difference between hemp and marijuana. Since the […]

Read More

What is ‘marijuana’? Name game limits cannabis entrepreneurs

The old debate about what to call the plant cannabis sativa L. is giving businesses real-world headaches in both new and established marijuana markets. Consider: Iowa allows medical marijuana but calls it something else. Texas restricts medical marijuana so severely that doctors must break the law to use the state’s program. California officials are struggling […]

Read More